Investing.com - Wave Life Sciences Ltd (NASDAQ: WVE) reported second quarter EPS of $-0.200, $0.13 better than the analyst estimate of $-0.330. Revenue for the quarter came in at $22.1M versus the consensus estimate of $7.94M.
Wave Life Sciences Ltd's stock price closed at $4.370. It is up 9.520% in the last 3 months and up 81.330% in the last 12 months.
Wave Life Sciences Ltd saw 2 positive EPS revisions and 1 negative EPS revisions in the last 90 days. See Wave Life Sciences Ltd's stock price’s past reactions to earnings here.
According to InvestingPro, Wave Life Sciences Ltd's Financial Health score is "fair performance".
Check out Wave Life Sciences Ltd's recent earnings performance, and Wave Life Sciences Ltd's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar